These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9444961)

  • 1. AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells.
    Gaozza E; Baker SJ; Vora RK; Reddy EP
    Oncogene; 1997 Dec; 15(25):3127-35. PubMed ID: 9444961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small unstable apoptotic protein, an apoptosis-associated protein, suppresses proliferation of myeloid cells.
    Baker SJ
    Cancer Res; 2003 Feb; 63(3):705-12. PubMed ID: 12566317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.
    Perrotti D; Bonatti S; Trotta R; Martinez R; Skorski T; Salomoni P; Grassilli E; Lozzo RV; Cooper DR; Calabretta B
    EMBO J; 1998 Aug; 17(15):4442-55. PubMed ID: 9687511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the apoptosis-associated tyrosine kinase (AATYK) expressed in the CNS.
    Tomomura M; Fernandez-Gonzales A; Yano R; Yuzaki M
    Oncogene; 2001 Mar; 20(9):1022-32. PubMed ID: 11314040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
    Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
    Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p120 nucleolar-proliferating antigen is a direct target of G-CSF signaling during myeloid differentiation.
    Khanna-Gupta A; Sun H; Zibello T; Lozovatsky L; Ghosh PK; Link DC; McLemore ML; Berliner N
    J Leukoc Biol; 2006 May; 79(5):1011-21. PubMed ID: 16641140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an alternatively spliced AATYK mRNA: expression pattern of AATYK in the brain and neuronal cells.
    Baker SJ; Sumerson R; Reddy CD; Berrebi AS; Flynn DC; Reddy EP
    Oncogene; 2001 Mar; 20(9):1015-21. PubMed ID: 11314039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcr/abl expression in 32D cl3(G) cells inhibits apoptosis induced by protein tyrosine kinase inhibitors.
    Laneuville P; Timm M; Hudson AT
    Cancer Res; 1994 Mar; 54(5):1360-6. PubMed ID: 8118826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells.
    Friedman AD
    Cancer Res; 1996 Jul; 56(14):3250-6. PubMed ID: 8764117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
    Forster K; Obermeier A; Mitina O; Simon N; Warmuth M; Krause G; Hallek M
    Ann Hematol; 2008 Mar; 87(3):183-93. PubMed ID: 17960378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family.
    Tomomura M; Morita N; Yoshikawa F; Konishi A; Akiyama H; Furuichi T; Kamiguchi H
    Neuroscience; 2007 Aug; 148(2):510-21. PubMed ID: 17651901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
    Gambacorti-Passerini C; le Coutre P; Mologni L; Fanelli M; Bertazzoli C; Marchesi E; Di Nicola M; Biondi A; Corneo GM; Belotti D; Pogliani E; Lydon NB
    Blood Cells Mol Dis; 1997 Dec; 23(3):380-94. PubMed ID: 9446752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
    Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
    Oncogene; 2000 Aug; 19(36):4151-8. PubMed ID: 10962576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, Jun-B and histone variants.
    Lord KA; Hoffman-Liebermann B; Liebermann DA
    Oncogene; 1990 Mar; 5(3):387-96. PubMed ID: 1690380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.